PSMB9 and nasopharyngeal carcinoma: There was a study assessed the efficacy of Ad-ΔLMP1-LMP2 transduced DCs vaccine in total 12 patients with NPC, this vaccine increased the activity of LMP1/2-specific T cells in vitro (64).